These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 2872958)

  • 21. Selective alpha 1-adrenergic antagonists: therapeutically relevant antihypertensive agents.
    Graham RM
    Am J Cardiol; 1984 Jan; 53(3):16A-20A. PubMed ID: 6141721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of doxazosin and enalapril in the treatment of mild and moderate essential hypertension.
    Taylor SH; Lee PS; Sharma SK
    Am Heart J; 1988 Dec; 116(6 Pt 2):1820-5. PubMed ID: 2904757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with doxazosin in general medical practice.
    Rosenthal J
    Am Heart J; 1988 Dec; 116(6 Pt 2):1748-57. PubMed ID: 2904745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-1 blockers. A new generation of antihypertensive agents.
    Humphreys JE; Waite MA
    J Clin Pharm Ther; 1989 Aug; 14(4):263-83. PubMed ID: 2571616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of coronary heart disease risk factors with doxazosin as monotherapy and in combination therapy.
    Rosenthal J
    Am Heart J; 1988 Dec; 116(6 Pt 2):1763-6. PubMed ID: 2904747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postjunctional selectivity of alpha-blockade with prazosin, trimazosin, and UK-33,274 in man.
    Singleton W; Saxton CA; Hernandez J; Prichard BN
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S145-51. PubMed ID: 6175830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of doxazosin versus atenolol in mild-to-moderate hypertension.
    Giorgi G; Legramante JM; Fioravanti G; Paies G; Legramante A
    Am Heart J; 1988 Dec; 116(6 Pt 2):1801-5. PubMed ID: 2904754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxazosin in the treatment of mild and moderate essential hypertension in general medical practice.
    van den Hogen AL
    Am Heart J; 1988 Dec; 116(6 Pt 2):1757-62. PubMed ID: 2904746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
    Constantine JW; Lebel W; Weeks R
    J Cardiovasc Pharmacol; 1984; 6(1):142-50. PubMed ID: 6199597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single-blind study of doxazosin in the treatment of mild-to-moderate essential hypertensive patients with concomitant noninsulin-dependent diabetes mellitus.
    Castrignano R; D'Angelo A; Pati T; Al Awady M; Tronca R; Crepaldi G
    Am Heart J; 1988 Dec; 116(6 Pt 2):1778-84. PubMed ID: 2904750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group.
    J Hum Hypertens; 1992 Jun; 6(3):181-4. PubMed ID: 1352827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-1 adrenoceptor blockade with doxazosin in hypertension: effects on blood pressure and lipoproteins.
    Ames RP; Kiyasu JY
    J Clin Pharmacol; 1989 Feb; 29(2):123-7. PubMed ID: 2565917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
    Silke B; Guy S; Humphreys JE
    J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive drugs interacting with alpha- and beta-adrenoceptors. A review of basic pharmacology.
    van Zwieten PA
    Drugs; 1988; 35 Suppl 6():6-19. PubMed ID: 2841084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Terazosin: a new long-acting alpha 1-adrenergic antagonist for hypertension.
    Frishman WH; Eisen G; Lapsker J
    Med Clin North Am; 1988 Mar; 72(2):441-8. PubMed ID: 2894488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials.
    Pool JL
    Am Heart J; 1991 Sep; 122(3 Pt 2):926-31. PubMed ID: 1678924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications.
    Colucci WS
    Ann Intern Med; 1982 Jul; 97(1):67-77. PubMed ID: 6124197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of tiodazosin, praxosin, trimazosin and phentolamine on blood pressure, heart rate and on pre- and postsynaptic alpha-adrenergic receptors in the rat.
    Buyniski JP; Pircio AW; Schurig JE; Campbell JA
    Clin Exp Hypertens (1978); 1980; 2(6):1039-66. PubMed ID: 6108841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxazosin: a newly developed, selective alpha 1-inhibitor in the management of patients with pheochromocytoma.
    Miura Y; Yoshinaga K
    Am Heart J; 1988 Dec; 116(6 Pt 2):1785-9. PubMed ID: 2904751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.